Crewe Advisors LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1730033
SALT LAKE CITY, UT
Position in VRTX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$279,658
+$56,388 QoQ
Shares Held
563
+12.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,266
of 1,745 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Crewe Advisors LLC holds $954,290 across 17 Biotechnology names. VRTX ranks #1 (29.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
563 | $279,658 | |
| 2 | NAUT |
Nautilus Biotechnology, Inc.
|
136,052 | $254,417 | |
| 3 | DFTX |
Definium Therapeutics, Inc.
|
1,999 | $94,032 | |
| 4 | BNTX |
BioNTech SE
|
809 | $75,277 | |
| 5 | MRNA |
Moderna, Inc.
|
728 | $50,981 | |
| 6 | MNKD |
Mannkind Corp
|
8,074 | $34,395 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
94 | $29,712 | |
| 8 | ATAI |
AtaiBeckley Inc.
|
5,540 | $29,195 |
All Filings in VRTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $279,658 | 563 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $223,270 | 500 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $228,493 | 504 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $196,211 | 501 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $174,518 | 392 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $193,443 | 399 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $161,080 | 400 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $261,840 | 563 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $243,734 | 520 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $216,111 | 517 | Shares | Sole | 2024-05-14 | |
| 2023-06-30 | $194,254 | 552 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $165,726 | 526 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $175,000 | 606 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $205,862 | 711 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $189,926 | 674 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $121,351 | 465 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $31,842 | 145 | Shares | Sole | 2022-02-10 | |
| 2020-09-30 | $8,163 | 30 | Shares | Sole | 2020-10-13 | |
| No filing history on record for this holder in this stock. | ||||||